The US contact lenses market is expected to grow at a CAGR of $% from 2022 to 2028 with an increasing number of eye inaccuracies among the younger population.
Lento Bio Inc. has synthesized cysteine derivatives reported to be useful for the treatment of presbyopia. An exemplified compound (Cpd in row 4 in tbl1 pg 20, claim 18) decreased in lens stiffness in ...
Eye-focused biotechs Tenpoint Therapeutics and Visus Therapeutics are joining forces, setting their sights on filing a new drug approval application next year for a presbyopia-correcting eye drop.
The merger brings together a late-stage, potentially best-in-class, presbyopia-correcting eye drop, Brimochol PF (carbachol/brimonidine tartrate fixed-dose combination), on track for New Drug ...
“We want to minimise the difference patients feel between putting a fresh lens in and the end of the day. Our Acuvue Oasys Max technology is about building comfort into the day.” he said. A more ...